Apellis Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Watson David O. | General Counsel | Sale | 781 | $67.77 | $52,928 | 103,390 | Feb 12, 2024 |
| Townsend Adam J. | Chief Commercial Officer | Sale | 1,148 | $67.77 | $77,800 | 92,453 | Feb 12, 2024 |
| Sullivan Timothy Eugene | Chief Financial Officer | Sale | 1,431 | $67.77 | $96,979 | 93,338 | Feb 12, 2024 |
| Francois Cedric | Chief Executive Officer | Sale | 3,962 | $67.77 | $268,505 | 313,662 | Feb 12, 2024 |
| Deschatelets Pascal | Chief Scientific Officer | Sale | 1,148 | $67.77 | $77,800 | 1,115,983 | Feb 12, 2024 |
| DeLong Mark Jeffrey | Chief Business & Strat Officer | Sale | 597 | $67.77 | $40,459 | 64,606 | Feb 12, 2024 |
| Watson David O. | General Counsel | Sale | 906 | $64.14 | $58,111 | 104,171 | Jan 29, 2024 |
| Townsend Adam J. | Chief Commercial Officer | Sale | 906 | $64.14 | $58,111 | 93,601 | Jan 29, 2024 |
| Sullivan Timothy Eugene | Chief Financial Officer | Sale | 906 | $64.14 | $58,111 | 94,769 | Jan 29, 2024 |
| Nicholson Nur | Chief Technical Officer | Sale | 835 | $64.14 | $53,557 | 67,507 | Jan 29, 2024 |
| Lewis Karen | Chief People Officer | Sale | 883 | $65.53 | $57,863 | 46,387 | Jan 29, 2024 |
| Francois Cedric | Chief Executive Officer | Sale | 2,843 | $64.14 | $182,350 | 317,624 | Jan 29, 2024 |
| Eisele Jeffrey | Chief Development Officer | Sale | 971 | $65.53 | $63,630 | 57,208 | Jan 29, 2024 |
| Deschatelets Pascal | Chief Scientific Officer | Sale | 874 | $64.14 | $56,058 | 1,117,131 | Jan 29, 2024 |
| DeLong Mark Jeffrey | Chief Business & Strat Officer | Sale | 367 | $64.14 | $23,539 | 65,203 | Jan 29, 2024 |
| Lewis Karen | Chief People Officer | Sale | 4,286 | $63.69 | $272,975 | 47,637 | Jan 23, 2024 |
| Eisele Jeffrey | Chief Development Officer | Sale | 7,378 | $63.69 | $469,905 | 58,458 | Jan 23, 2024 |
| Francois Cedric | Chief Executive Officer | Sale | 13,431 | $65.00 | $873,015 | 320,467 | Jan 22, 2024 |
| Watson David O. | General Counsel | Sale | 4,184 | $65.00 | $271,960 | 105,077 | Jan 22, 2024 |
| Townsend Adam J. | Chief Commercial Officer | Sale | 3,413 | $65.00 | $221,845 | 94,507 | Jan 22, 2024 |
| Sullivan Timothy Eugene | Chief Financial Officer | Sale | 3,551 | $65.00 | $230,815 | 95,675 | Jan 22, 2024 |
| Nicholson Nur | Chief Technical Officer | Sale | 2,593 | $65.00 | $168,545 | 68,342 | Jan 22, 2024 |
| Lewis Karen | Chief People Officer | Sale | 1,738 | $65.00 | $112,970 | 51,923 | Jan 22, 2024 |
| Eisele Jeffrey | Chief Development Officer | Sale | 1,607 | $65.00 | $104,455 | 65,836 | Jan 22, 2024 |
| Deschatelets Pascal | Chief Scientific Officer | Sale | 3,913 | $65.00 | $254,345 | 1,118,005 | Jan 22, 2024 |
| DeLong Mark Jeffrey | Chief Business & Strat Officer | Sale | 1,384 | $65.00 | $89,960 | 65,570 | Jan 22, 2024 |
| Chopas James George | VP/Chief Accounting Officer | Sale | 1,061 | $65.00 | $68,965 | 39,067 | Jan 22, 2024 |
| Eisele Jeffrey | Chief Development Officer | Sale | 5,207 | $65.58 | $341,475 | 67,443 | Jan 17, 2024 |
| Lewis Karen | Chief People Officer | Sale | 3,276 | $65.58 | $214,840 | 53,661 | Jan 17, 2024 |
| Deschatelets Pascal | Chief Scientific Officer | Sale | 1,632 | $66.81 | $109,034 | 1,121,918 | Jan 16, 2024 |
| Chopas James George | VP/Chief Accounting Officer | Sale | 864 | $66.81 | $57,724 | 40,128 | Jan 16, 2024 |
| Lewis Karen | Chief People Officer | Sale | 1,632 | $66.81 | $109,034 | 56,937 | Jan 16, 2024 |
| DeLong Mark Jeffrey | Chief Business & Strat Officer | Award / Grant | 16,963 | — | — | 68,585 | Jan 16, 2024 |
| Nicholson Nur | Chief Technical Officer | Award / Grant | 19,508 | — | — | 72,792 | Jan 16, 2024 |
| Watson David O. | General Counsel | Award / Grant | 23,748 | — | — | 113,501 | Jan 16, 2024 |
| Townsend Adam J. | Chief Commercial Officer | Award / Grant | 23,748 | — | — | 100,155 | Jan 16, 2024 |
| Sullivan Timothy Eugene | Chief Financial Officer | Sale | 2,235 | $66.81 | $149,320 | 99,226 | Jan 16, 2024 |
| Baumal Caroline | Chief Medical Officer | Award / Grant | 25,445 | — | — | 58,376 | Jan 16, 2024 |
| Francois Cedric | Chief Executive Officer | Award / Grant | 72,094 | — | — | 341,749 | Jan 16, 2024 |
| Eisele Jeffrey | Chief Development Officer | Sale | 438 | $66.81 | $29,263 | 72,650 | Jan 16, 2024 |
| Baumal Caroline | Chief Medical Officer | Sale | 2,751 | $60.05 | $165,198 | 32,931 | Jan 4, 2024 |
| FONTEYNE PAUL R. | — | Award / Grant | 3,341 | — | — | 16,438 | Jan 1, 2024 |
| O'Brien Stephanie Monaghan | — | Award / Grant | 3,341 | — | — | 11,438 | Jan 1, 2024 |
| Chan Gerald | — | Award / Grant | 3,341 | — | — | 11,438 | Jan 1, 2024 |
| Dunlop A. Sinclair | — | Award / Grant | 3,341 | — | — | 132,018 | Jan 1, 2024 |
| Machiels Alec | — | Award / Grant | 3,341 | — | — | 370,761 | Jan 1, 2024 |
| Eisele Jeffrey | Chief Development Officer | Sale | 68 | $57.86 | $3,934 | 53,815 | Dec 27, 2023 |
| Watson David O. | General Counsel | Sale | 1,605 | $57.00 | $91,485 | 92,053 | Dec 19, 2023 |
| Dunlop A. Sinclair | — | Option Exercise | 6,274 | $13.19 | $82,754 | 128,677 | Dec 14, 2023 |
| SCHEIBLER LUKAS | Chief Research Officer | Option Exercise | 10,000 | $13.85 | $138,500 | 78,299 | Dec 1, 2023 |